UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012998
Receipt number R000014373
Scientific Title Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide
Date of disclosure of the study information 2014/02/03
Last modified on 2017/02/02 17:32:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide

Acronym

Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide

Scientific Title

Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide

Scientific Title:Acronym

Assessment of end-tidal carbon dioxide for endoscopic screening or therapy using carbon dioxide

Region

Japan


Condition

Condition

Patients with the necessity of receiving the routine endoscopic examination or endoscopic therapy

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is assessment of the change of etCO2 before, under and after the routine endoscopic examination or endoscopic therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

the change of etCO2 before, under and after the routine endoscopic examination or endoscopic therapy

Key secondary outcomes

1. the change of arterial blood gas analysis before and after the routine endoscopic examination or endoscopic therapy
2. relationship between the respiratory function test and etCO2
3. relationship between arterial blood gas analysis and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy
4. relationship between age and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy
5. relationship between gender and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy
6. relationship between height, weight, body mass index and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy
7. relationship between past history, history of present illness, past herapy and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy
8. relationship between blood pressure and etCO2 before, under and after the routine endoscopic examination or endoscopic therapy
9. adverse event by this study


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with the necessity of receiving the routine endoscopic examination or endoscopic therapy using CO2

2. Patients who participated oneself with enough understanding after receiving enough explanation



Key exclusion criteria

1. Patients who have PaO2<60mmHg or PaCO2>45mmHg before routine endoscopic examination or endoscopic therapy using CO2

2. Patients with the coagulation disorder

3. Patients who are judged inappropriate by principal investigator or sub-investigator

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobuaki Azemoto

Organization

Ehime Prefectural Central Hospital

Division name

Gastroenterology Center

Zip code


Address

Kasugamachi, Matsuyama, Ehime

TEL

089-947-1111

Email

azemotonobu@gmmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Nobuaki Azemoto

Organization

Ehime Prefectural Central Hospital

Division name

Gastroenterology Center

Zip code


Address

Kasugamachi, Matsuyama, Ehime

TEL

089-947-1111

Homepage URL


Email

azemotonobu@gmail.com


Sponsor or person

Institute

Gastroenterology Center, Prefectural Central Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛媛県立中央病院(愛媛県)


Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The use of CO2 was well tolerated in all patients without any adverse events.
The change of EtCO2 among before, under and after procedure was not significantly
PaCO2 after procedure was significantly higher than PaCO2 before procedure.
PaCO2 before procedure was significantly higher than EtCO2 before procedure. PaCO2 after procedure was also significantly higher than EtCO2 after procedure.
The change of EtCO2 was not significantly by respiratory functional test.
The change of EtCO2 was not significantly by gender.
The change of EtCO2 was not significantly by smoking history.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 01 Month 22 Day

Date of IRB


Anticipated trial start date

2014 Year 02 Month 03 Day

Last follow-up date

2015 Year 03 Month 30 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information

Prospective cohort study


Management information

Registered date

2014 Year 01 Month 28 Day

Last modified on

2017 Year 02 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014373


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name